Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 4223 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Cephalon seeks FDA approval for cancer painkiller

The tablet delivers the opioid painkiller through the oral mucus membrane utilizing a proprietary enhanced absorption technology. “Expanding our pain care franchise is integral to Cephalon’s growth strategy,”

MorphoSys and Centocor embark on new antibody project

Centocor will carry out preclinical and clinical development and subsequent marketing of resulting products. In exchange, MorphoSys stands to receive licensing and milestone payments, in addition to royalties,

FDA allows late-stage BioAlliance antifungal trial

Miconazole Lauriad is a once-daily 50mg extended-release tablet being investigated as a first-line local treatment for oropharyngeal candidiasis (OPC), an oral fungus. OPC infections are frequent within patients

Servier heart drugs get European backing

The European Medical Evaluation Agency (EMEA) recommended that Servier’s drug Coversyl should have its indication extended to include the treatment of high blood pressure in patients with stable

Chiron rejects Novartis takeover offer

Novartis, which already has a 42% stake in Chiron, made the offer to purchase the remaining shares on September 1, 2005 for $40 per share, or approximately $4.5